WO1997017104A1 - Improved flexible source wire for localized internal irradiation of tissue - Google Patents
Improved flexible source wire for localized internal irradiation of tissue Download PDFInfo
- Publication number
- WO1997017104A1 WO1997017104A1 PCT/US1996/017260 US9617260W WO9717104A1 WO 1997017104 A1 WO1997017104 A1 WO 1997017104A1 US 9617260 W US9617260 W US 9617260W WO 9717104 A1 WO9717104 A1 WO 9717104A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wire
- tube
- radioactive
- source wire
- source
- Prior art date
Links
- 230000002285 radioactive effect Effects 0.000 claims abstract description 184
- 239000000463 material Substances 0.000 claims abstract description 61
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910000990 Ni alloy Inorganic materials 0.000 claims abstract description 9
- 229910001069 Ti alloy Inorganic materials 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 67
- 239000002775 capsule Substances 0.000 claims description 45
- 230000008569 process Effects 0.000 claims description 28
- 230000005855 radiation Effects 0.000 claims description 27
- 239000004593 Epoxy Substances 0.000 claims description 14
- 201000010099 disease Diseases 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
- 229910052751 metal Inorganic materials 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 12
- 239000012857 radioactive material Substances 0.000 claims description 12
- 239000010936 titanium Substances 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 230000004075 alteration Effects 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 230000007246 mechanism Effects 0.000 claims description 6
- 229910052719 titanium Inorganic materials 0.000 claims description 6
- 238000005452 bending Methods 0.000 claims description 5
- GKOZUEZYRPOHIO-IGMARMGPSA-N iridium-192 Chemical compound [192Ir] GKOZUEZYRPOHIO-IGMARMGPSA-N 0.000 claims description 5
- -1 platium Chemical compound 0.000 claims description 5
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 239000007769 metal material Substances 0.000 claims description 4
- 229910052759 nickel Inorganic materials 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000007767 bonding agent Substances 0.000 claims description 2
- 230000001680 brushing effect Effects 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 238000007598 dipping method Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000010422 painting Methods 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims 9
- 230000001678 irradiating effect Effects 0.000 claims 6
- 239000007800 oxidant agent Substances 0.000 claims 4
- 230000003014 reinforcing effect Effects 0.000 claims 2
- 238000009713 electroplating Methods 0.000 claims 1
- 238000005538 encapsulation Methods 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000004848 polyfunctional curative Substances 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 abstract description 5
- 230000033001 locomotion Effects 0.000 abstract description 4
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 description 18
- 208000037803 restenosis Diseases 0.000 description 17
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 14
- 238000003466 welding Methods 0.000 description 13
- 238000002399 angioplasty Methods 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 229910052741 iridium Inorganic materials 0.000 description 11
- 239000000835 fiber Substances 0.000 description 10
- 239000003292 glue Substances 0.000 description 10
- 238000000227 grinding Methods 0.000 description 10
- 229910045601 alloy Inorganic materials 0.000 description 7
- 239000000956 alloy Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 230000010339 dilation Effects 0.000 description 6
- 208000031481 Pathologic Constriction Diseases 0.000 description 5
- 238000004026 adhesive bonding Methods 0.000 description 5
- 210000004351 coronary vessel Anatomy 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000005553 drilling Methods 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000036262 stenosis Effects 0.000 description 4
- 208000037804 stenosis Diseases 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005476 soldering Methods 0.000 description 3
- 238000002725 brachytherapy Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000007887 coronary angioplasty Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 239000002901 radioactive waste Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 229910000679 solder Inorganic materials 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 229920006335 epoxy glue Polymers 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000002784 sclerotic effect Effects 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1002—Intraluminal radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1025—Wires
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49888—Subsequently coating
Definitions
- the present invention relates generally to radioactive source wires used to irradiate body tissue in the treatment of disease. More particularly, the present invention relates to the use of an elongated radioactive source wire with increased flexibility for the localized delivery of radiation to diseased tissue.
- ischemic heart disease which, generally speaking, is an imbalance between r.vocardial oxygen supply and demand. This imbalance is most often due to obstruction of large coronary arteries by sclerotic plaque and is related to either an absolute decrease in coronary blood flow or an inability to increase coronary blood flow relative to the needs of the heart. Ischemic heart disease is most commonly associated with chest pain, an acute heart attack, an abnormal ventricular rhythm and sudden death. Although various medical and surgical therapies may improve the quality of lifestyle of many patients with this disease, these therapies do not favorably change the underlying cause for the coronary vessel narrowing, nor do they stop its progression.
- catheters have been developed which may be effectively inserted into blood vessels and maneuvered through a vascular tree.
- a balloon may be used with such catheters to expand inside the vessel and to open blockages found therein.
- a guiding catheter is percutaneously introduced into the vascular system of a patient through an artery and advanced therein until the distal tip of the guiding catheter is appropriately positioned.
- a dilation catheter having a balloon on the distal end thereof and a guide wire are slidably disposed and introduced through the guiding catheter.
- the guide wire is first advanced through the distal tip of the guiding catheter until the distal end of the guide wire crosses the lesion to be dilated.
- the dilation catheter is then advanced over the previously introduced guide wire until the dilation balloon on the distal extremity of the dilation catheter is properly positioned inside the lesion.
- the balloon portion of the dilation catheter is then inflated to a predetermined size to radially compress the atherosclerotic plaque of the lesion against the inside of the artery wall to thereby reduce the annular stenosed area. After a period of time, the balloon is deflated so that blood flow is resumed, allowing the dilation catheter to be removed.
- a major problem encountered in a significant number of patients treated by this procedure is the subsequent narrowing of the artery after the expansion treatment.
- Palmaz discloses an expansible vascular graft which is expanded within a blood vessel by an angioplasty balloon to dilate and expand the lumen of the blood vessel.
- the Palmaz method and apparatus leaves the expandable vascular graft in place to ideally prevent recurrence of stenosis in the body passageway.
- the present invention is believed to provide a unique method and apparatus to reduce the restenosis rate of occurrence following an angioplasty or like-intended procedure.
- PTCA percutaneous transluminal coronary angioplasty
- restenosis occurs in 30-40% of cases following successful PTCA and is most frequently observed between 3 and 6 months after the procedure. Late restenosis in the months after angioplasty reduces the initial success rate of 90% to 60-70% after six months. Although the incidence of success and associated complications has improved significantly over the last decade, the risk of restenosis has not changed. Hence, cf the more than 300,000 coronary arteries subjected to angioplasty during 1990, 30-40% can be expected to restenose. As a result, there is a definite need for a method to reduce this high incidence of restenosis.
- Two (2) approaches are currently employed to reduce restenosis.
- One approach involves the use of a revascularization device, such as the laser catheter, thermal catheter or stent to debulk plaque and create a smooth lumen to minimize turbulence and platelet aggregation along the vessel wall.
- Another approach to reduce restenosis involves infusing a drug which modulates cell growth into the target artery before, during, or after the angioplasty to inhibit the profileration of smooth muscle cells.
- antiplatelet agents such as aspirin and dipyridamole
- anticoagulants such as heparin
- the present invention satisfies this need and provides related advantages as well. Radiation is used to treat cancer and other diseases of the body.
- Radioactive source or sources are positioned in the area needing treatment. Depending on the shape, size and delivery means of the radioactive sources, the sources are either kept permanently in the body or removed after
- the term temporary implants describes the procedure of maneuvering a radioactive source or sources to the treatment site utilizing a transport catheter or tube which has been previously placed in the vicinity of this treatment site.
- the transport catheter and temporary implant can simultaneously be maneuvered to the treatment site.
- these sources and the transport catheter or tube are removed from the body. Since the radioactive source or sources may encounter a tortuous path in various arteries, veins, ducts, or the like inside the body to reach the treatment site, the radioactive source is usually attached by some device to a flexible drive member. This source and the drive member may be used many times, and, therefore must be able to withstand the many bends it encounters when it is maneuvered to the treatment site or removed therefrom, without breaking.
- U.S. Patent 5,084,002 issued to Liprie describes an ultra-thin high dose iridium source included within an oversized hole drilled inside the end of a solid platinum wire. Drilling a hole into a thin wire is very difficult since the maximum depth the hole can be drilled is equal to approximately seven times the outside diameter of the wire. To drill a hole deeper than this is extremely difficult due to the drifting of the drill as it burrows the hole. This drifting can lead to a thinning of the cavity walls which greatly increases the chances of breakage. This breakage is often disastrous, resulting in unwarranted radiation exposure. A larger outside diameter wire will be needed to compensate for the drifting and still allow the walls of the cavity to be thick enough to withstand stress. Unfortunately, this larger diameter wire might be too large to fit into many constricted areas of the body. As described in Liprie '002 one can drill a cavity inside a
- U.S. Patent No. 5,282,781 would not work on a memory resistant alloy. As soon as a memory resistant alloy had been drawn through a die, the alloy would resume its original shape. If the memory resistant alloy was drawn beyond the threshold of its elasticity, then the memory resistant properties of the alloy would be destroyed.
- radioactive source wire that has an extremely small diameter and is flexible, yet has sufficient tensile strength to traverse a tortuous route of bends and turns without breaking.
- the present invention is directed to a flexible source wire for the radiation treatment of disease in which the source wire contains a radioactive core and is easily maneuvered to the site of treatment through various conduits in the body.
- One general embodiment of the source wire of the present invention includes a thin, generally cylindrical, elongated, flexible housing tube having a distal end and a proximal end.
- the housing tube further comprises an unmodified section at its distal end and a modified segment at its proximal end, where the wall thickness of the modified segment is thinner than the wall thickness of the unmodified section.
- a plug seals the lumen of the unmodified section from the lumen of the modified segment which contains a radioactive core. Both ends of the source wire are sealed and at least the proximal end is rounded to ease its movement through the tortuous bends and turns as it travels to the treatment site.
- An alternative embodiment of the source wire has a tapered section, having a tapered internal diameter that goes from the larger internal diameter of the modified segment to the smaller internal diameter of the unmodified section.
- Other embodiments may also include a backbone wire that extends throughout the unmodified section to the tapered section.
- Preferred embodiments of the present invention will have a housing tube and a plug
- the flexible source wire described herein may have a backbone wire or plug that is tapered at the end closest to the radioactive core.
- the tapered end of the backbone wire or plug terminates next to the radioactive core in a rounded area shaped like a ball.
- the radioactive core positioned within the proximal end of the housing tube, may exist openly within the housing tube or may be localized in an open-ended capsule or may be encapsulated by a thin-walled, flexible material or coating that allows the passage of neutrons.
- One advantage of the present invention is that it can be made with a smaller diameter housing tube than the source wires that are currently available.
- the source wire has a sufficient tensile strength and flexibility to withstand the stresses encountered when the source wire is maneuvered to the site of treatment.
- Yet another feature and advantage of the present invention is that it provides a novel mechanism for transferring the stress encountered by the metal housing tube as the source wire is maneuvered to the treatment site from the weakest portion of the source wire to the strongest portion of the source wire.
- the source wire is made of a material that can undergo a 1% strain with less than a 1% alteration in its original conformation.
- the source wire will exhibit flexibility similar to a tube and have the tensile strength properties closer to a solid wire.
- An additional feature and advantage of the present invention is that the radioactive source is visible with a fluoroscope.
- radioactive material of the radioactive source is sealed within the proximal end of the source wire.
- Still yet another feature and advantage of the present invention is that the radioactive source is long enough to treat the entire length of an angioplasted vascular stenosis.
- FIGURE 1 is a partial cross-section of one embodiment of a source wire having a housing tube with a thicker walled unmodified section, a thinner walled modified segment, a plug between the modified and unmodified sections and a radioactive core all enclosed within the housing tube;
- FIGURE 2 is a partial cross-section of another embodiment of a source wire having a housing tube with a thicker walled unmodified section, a thinner walled modified segment, a tapered section adjoining the modified and unmodified sections, a plug between the modified and unmodified sections and a radioactive core all enclosed within the housing tube;
- FIGURE 3A shows the embodiment of the source wire illustrated in FIGURE 2 in an unstressed, state;
- FIGURE 3B shows the tapered segment allowing the source wire assembly to pivot or start a turn without stress being applied to the thin-walled modified segment of the source wire;
- FIGURE 3C shows how the tapered segment transfers the stress from the thin-walled modified segment to the thicker walled unmodified section of the source wire as the source wire negotiates a tighter turn
- FIGURE 3D shows how the tapered segment allows the stress to be transferred to the thicker walled unmodified section of the source wire as the source wire negotiates a very tight turn
- FIGURE 4 is a partial cross-section of another embodiment of a source wire illustrating an alternative embodiment of the plug;
- FIGURE S is a partial cross-section of another embodiment of a source wire illustrating yet another alternative embodiment of the plug
- FIGURE 6 is a partial cross-section of another embodiment of a source wire without a plug and where the radioactive core is encapsulated in a neutron permeable material
- FIGURE 7 is a partial cross-section of another embodiment of a source wire having a flexible backbone wire running throughout the entire unmodified section of the housing tube;
- FIGURE 8 is a partial cross-section of another embodiment of a source wire illustrating an alternative embodiment of a backbone wire
- FIGURE 9 is a partial cross-section of another embodiment of a source wire illustrating an alternative embodiment of an encapsulated radioactive core; and FIGURE 10 shows a partial cross-section of a source wire positioned in a heat sink before its proximal end is sealed.
- the present invention relates to the design and manufacture of improved source wires for delivering radioactivity to a site of treatment within a human or animal body.
- the invention relates to a novel source wire design that provides improved source wire flexibility and strength such that the improved source wire can survive the stress encountered when it is subjected to the manipulations necessary to maneuver the source wire to and from an internal treatment site for the localized delivery of radiation to diseased tissue.
- the present invention may be used to treat cancer, stenosis, or other diseases of the body.
- the use of the present invention in the treatment of stenosis is described in co-pending U.S. patent application entitled "Method and Apparatus for Treating Stenosis," Serial No. 08/220,681, and is hereby incorporated by reference herein.
- FIGURE 1 it is emphasized that the Figures, or drawings, are not intended to be to scale. For example, purely for the sake of greater clarity in the drawings, wall thickness and spacings are not dimensioned as they actually exist in the assembled embodiments.
- FIGURE 1 illustrates a first embodiment of a source wire 10. Among the components of the source wire 10 is
- tube 120 an elongated, flexible metal housing tube 120. Since this housing tube 120 is used to maneuver the radioactive core to a remote treatment site, the length of the tube must be adequate to reach the treatment site when the source wire 10 is inserted through a catheter implanted in a patient's body for that purpose. Typically, tube 120 will have a length of at least 100 cm and may extend for a much greater distance.
- the tubing to be used should be as small as practical and still have the tensile strength, flexibility, and elongation properties necessary to withstand the pressures put upon the source wire while it is maneuvered throughout the body.
- the outside diameter of housing tube 120 will typically range from about 0.012" to about 0.018" and is preferably about 0.014".
- a preferred housing tube 120 is constructed from a material that can accept up to a 1% strain with less than a 1% alteration in its original shape (i.e., a material that exhibits little or no memory retention when bent) . Most metals such as stainless steel will incur a permanent alteration in shape when subjected to as little as a 0.1% strain.
- a material that exhibits little or no memory retention when bent is Tinel Alloy BB, a titanium/nickel alloy, manufactured by Raychem
- Nitinol® manufactured by Shape Memory Alloys, Sunnyvale, California.
- Tinel Alloy BB, and other such nickel/titanium alloys are comprised of about equal quantities of nickel and titanium, such as an alloy composed of about 55% nickel and about 45% titanium.
- Tube 120 has two ends, one of which will ultimately constitute the proximal end 140 and the other the distal end 150 of source wire 10.
- housing tube 120 may be sealed in any number of ways.
- the proximal end 140 should be rounded to facilitate the movement of source wire 10 through the bends and turns of the vasculature, or other treatment sites.
- Preferred embodiments of housing tube 120 will have an internal diameter that is 25 to 60% of the outside diameter. Commonly an internal diameter is selected that is 0.008" smaller than the outside diameter. The internal diameter will vary according to the external diameter of the tubing used. For example, tubing that has an external diameter of about 0.012" will commonly have an internal diameter of about 0.004" while tubing having an outside diameter of about 0.018" may have an internal diameter of about 0.010".
- Housing tube 120 will be modified at its proximal end to accept a radioactive core 160, described below. A short segment of housing tube 120, said segment at least the length of radioactive core 160, will have material removed from the inner surface 130 of housing tube 120 to create a modified segment 170. Typically at least 0.002"
- Preferred embodiments have an internal diameter of modified segment 170 that is about 0.004" wider than the internal diameter of the unmodified section ISO of tube 120 and the wall thickness of the modified section will be at least 0.002" thinner than the wall thickness of the unmodified section of tube 120.
- the increased wall thickness of unmodified section is about 0.004" wider than the internal diameter of the unmodified section ISO of tube 120 and the wall thickness of the modified section will be at least 0.002" thinner than the wall thickness of the unmodified section of tube 120.
- source wire 10 takes advantage of a tube construction.
- Modified section 170 has a thinner wall thickness and is more flexible than the unmodified section 180. Removal of material from the inside diameter of the proximal end of tubing 120 to provide a thinner wall along modified segment 170, will substantially increase the flexibility of modified segment 170. This increased flexibility at the front end of the source wire will allow the source wire to maneuver easier through tight bends and curves.
- a second component of source wire 10 is plug 190.
- Plug 190 provides a seal between modified segment 170 and the unmodified section 180 of tube 120.
- Plug 190 serves to keep all radioactivity, including any radioactive flakes or oxidized material issuing from radioactive core 160, from entering the lumen of unmodified section 180.
- plug 190 serves to contain all radioactivity within the proximal end of source wire 10.
- One advantage in containing all radioactivity within a short segment of the source wire e.g., within modified segment 170
- a preferred embodiment of plug 190 has a rounded surface 195 facing the proximal end of tubing 120 which abuts radioactive core 160 as seen in FIGURE 1.
- the rounded end 195 allows for greater pivoting of the source wire assembly while reducing stress on the housing material.
- a third component of source wire 10 is a radioactive core 160.
- Radioactive core 160 may be composed of a variety of different radioisotopes, some of which are Ir-192, Cs-137, Co-57, Co-60, Sr-89, Sr-90, P-32, Y-90, Au-198, 1-125, Pd-103, Se-75, or Ru-106.
- the preferred embodiment of core 160 will consist of a substantially pure iridium, which has been irradiated in a nuclear reactor to produce Ir-192 of a predetermined strength appropriate to its weight.
- Preferred embodiments of the present invention have a radioactive core 160 that is flexible and has rounded ends to allow pivoting and bending of the core 160.
- a preferred embodiment of the invention has a radioactive core 160 that is at least 20 mm in length and emits approximately 380 keV of energy. By spreading out the 380 keV emitted over at least a 20 mm distance, core
- radioactive core 160 is directly visible with a fluoroscope.
- the energy emitted by radioactive core 160 and the length of the source of radioactivity will vary with different embodiments of the invention, the preferred embodiment will have a radioactive core that can be seen with a fluoroscope.
- This feature provides a distinct advantage over the source wires that are currently available that have a radioactive iridium core of 10 mm or less in length. These point sources emit the equivalent 380 keV of energy in a less diffused manner.
- the emitted energy hits the fluoroscope directly and overrides its ability to visualize the radioactive source. Therefore, the radioactive cores of currently available source wires are not directly visible with a fluoroscope and must be positioned inside the body without the visual confirmation allowed with the present invention.
- Point sources also require a technique called "micro-stepping" in order to treat bodily diseases.
- Point sources consist of a radioactive core that is very short in length (often just a few millimeters long) and contain a highly concentrated amount of radioactive material. This type of source must sit precisely in one position for an exact amount of time and then be either retracted or advanced the length of the radioactive core to treat the next segment of the diseased tissue.
- the point source of radioactive material is much shorter than the length of the desired treatment area, treatment of the diseased tissue must occur in "micro-steps" in order to treat the entire length of the diseased tissue.
- the preferred embodiment of this invention has a radioactive core length greater than or equal to 20mm, with the radioactivity evenly spread over the entire core length. Thus, the entire diseased tissue can often be treated with a single placement of the radioactive source, thus eliminating the need to micro-step a highly concentrated point source. Use of this invention will allow a much safer and more precise treatment to be given.
- Core 160 has a diameter that is smaller than the inner diameter of modified segment 170 and larger than the inner diameter of unmodified section 180.
- a preferred embodiment of the invention has a core 160 that is about 0.005" in diameter.
- Core 160 will preferably have a diameter ranging from about 0.003" to about 0.009" depending on the outside diameter of the housing tube 120.
- Core 160 is inserted in the proximal end of the lumen of tube 120 and is pushed inward until core 160 abuts plug 190 or the proximal end 185 of the unmodified section 180 of tube 120.
- a plurality of radioactive cores 160 may also be employed in the present invention.
- a preferred embodiment will seal and round proximal end 140 using an arc welder, such as a tungsten inert gas (or TIG) welder.
- arc welder such as a tungsten inert gas (or TIG) welder.
- TIG tungsten inert gas
- FIGURE 2 illustrates a second embodiment 20 of the present invention.
- This embodiment is similar in many respects to the embodiment shown in FIGURE 1 and will have the same reference numerals as the respective elements pictured in FIGURE 1.
- This embodiment also has an elongated cylindrical metal housing tube 120, similar in dimensions and characteristics to the tube described with respect to FIGURE 1.
- the embodiment of the source wire shown in FIGURE 2 has a tapered section 275 which adjoins unmodified section 180 on its distal end and modified segment on its proximal end.
- Tapered section 275 can be created using a tapered reamer, a tapered drill bit, a series of drill bits, a series of EDM probes, or a series of laser probes so that a portion of the inner surface 130 will be reconfigured to taper from the larger internal diameter of modified segment 170 to the smaller internal diameter of the unmodified section 180 of tube 120. Tapered section 275 will typically be at least five (5) millimeters long.
- Internal taper 275 allows the source wire to bend several degrees before stress is applied to the housing of tube 120 by the radioactive core 160. Even when the wire bends sufficiently to apply stress to the tube
- the design of source wire 20 will allow the stress on the housing material to be transferred from its weakest area (i.e., the modified segment 170 with its thinner wall) to its strongest area (i.e., the unmodified section 180 with its thicker wall) as shown in FIGURES 3A
- FIGURE 3A shows one embodiment of the source wire in an unstressed state.
- FIGURE 3B illustrates how tapered section 275 and modified segment 170 allow radioactive core 160 to pivot about the rounded end 295 of plug 290 when the source wire enters a turn without applying stress to the thinner walled modified segment 170.
- FIGURES 3C and 3D illustrate how the tapered section 275 allows the stress to be transferred to the thicker walled unmodified section 180 as the source wire negotiates tighter and tighter turns.
- This novel design feature not only increases the flexibility of the proximal end of the source wire but it also adds to the stability of the source wire by making it less likely to break at the proximal end where the radioactive core is located.
- Plug 290 provides a seal between unmodified section 180 and tapered section 275.
- Plug 290 has one end that fits into the lumen of unmodified section 180 and another end that is rounded and abuts radioactive core 160. This rounded end 295 allows the greater pivoting of the source wire while reducing stress on the housing material as illustrated in FIGURE 3A - 3D.
- FIGURE 4 shows another embodiment of the plug used to seal the end of the lumen of the unmodified section 180 from radioactive materials. Plug 490 is situated at
- Plug 490 does not necessarily have a rounded edge as is seen in the preferred embodiments. However, plug 490 can be easily and inexpensively implanted, as for example, by using a long needle to inject an epoxy glue into the proximal end of the lumen of unmodified section 150. Plug 490 may also be a flexible seal composed of a flexible material such as latex that has been glued in place at or about the junction of unmodified section 180 and tapered section
- Plug 590 illustrated in FIGURE 5, is made of a memory resistant material such as described above. Plug 590 is attached to the inner surface 130 of the unmodified section 180 and extends into the distal end of tapered section 275 where it abuts radioactive core 160. Plug 590 is tapered as it extends towards the radioactive core and terminates in a rounded area 595 approximating the shape of a ball. A preferred embodiment of taper 597 goes from a 100% width where plug 590 is attached to the unmodified section 180 to a width that is from about 30% to 70% of that width where the tapered portion of plug 590 is attached to rounded area 595.
- This configuration keeps rounded area 595 and radioactive core 160 suspended within the tapered section
- source wire 50 can take advantage of the full flexibility of the tapered section 275 without interference from either plug 590 or radioactive core 160.
- the space left between the inner wall of tubing 120 and rounded area 595 is insufficient to allow radioactive core 160 to pass beyond the rounded area 595 into the lumen of unmodified section 180.
- the design of source wire 50 allows it to release some of the stress on the outer wall of housing tube 120 whenever the source wire bends to traverse a tight corner. The stress placed on the rounded area 595 will cause the tapered portion 597 of plug 590 to crumple. However, if plug 590 is made of a memory resistant material then plug 590 will resume its original shape when the stress is removed from the rounded area 595.
- FIGURE 6 shows yet another embodiment of the present invention.
- the source wire illustrated in FIGURE 6 contains a plurality of radioactive cores 660 enclosed in a thin-walled capsule 680.
- Capsule 680, illustrated in FIGURE 6 surrounds the radioactive core and will function to contain all radioactive material within the capsule.
- radioactive core(s) may be placed in an open-ended capsule (not illustrated herein) .
- the open end would face the proximal end of the source wire.
- the radioactive core(s) are located in the capsule inserted into tube 120 so that the distal end 670 of the capsule 680 lies at or near the intersection of the unmodified section 180 and the tapered section 275.
- the plug is not needed to prevent any radioactive material from entering the lumen of the unmodified section.
- Capsule 680 should be flexible and thin.
- the wall of capsule 680 must be made of a material that allows the passage of neutrons without obtaining significant radioactivity itself. If the capsule material should become radioactive by neutron flux, the material and any contaminants of that material should have a short half-life as compared to the radioactive core. It is important that the capsule 680 should emit less than 10% of the radiation emitted by radioactive cores 660.
- the capsule may be made in a variety of ways. For example, it may be made from a carbon filament sealed with epoxy at both ends, or it may be a very thin metallic substance (e.g., titanium, a high purity aluminum such as aluminum 1100, platinum, or the titanium/nickel alloy described previously) with both ends welded, soldered, or glued closed.
- the iridium will be encapsulated before it is irradiated to form Ir-192 and the capsule 680 will allow the passage of neutrons to irradiate the core.
- the preferred embodiment of capsule 680 will be rounded on both ends. The purpose of having a rounded distal end 670 of capsule 680 is to allow greater pivoting of the source wire 60 while reducing stress to the housing material.
- the preferred embodiment has a single capsule 680, a plurality of capsules could be employed in the present invention, or a plurality of cores 660 could be incorporated within a single capsule 680 as shown in FIGURE 6.
- radioactive core 660 to have a thin coating of a neutron permeable material.
- the coating may be an electroplated coating of a material such as gold, titanium, platinum, etc.
- the coating may also be made of a non-metallic material such as a hardening agent (e.g., glue or acrylic) .
- the coating may be applied to core 660 by brushing, dipping, painting or molecularly bonding the coating material to the outer surface of core 660.
- FIGURE 7 illustrates a preferred embodiment of the present invention.
- This embodiment of a flexible source wire 70 is similar in many respects to the other embodiments of the present invention. Therefore the elements in FIGURE 7 corresponding to similar elements in the previous figures will be given the same reference numerals as their respective elements in the previous figures.
- Source wire 70 contains an optional flexible backbone wire 720, as illustrated in FIGURE 1, which has a diameter slightly less than the inner diameter of unmodified section 180, and is preferably about 0.001" smaller in diameter than the internal diameter of unmodified section 180.
- Backbone wire 720 is positioned within the lumen of unmodified section 180 from the distal end 150 to the tapered section 275 of tube 120. The distal end of the backbone wire 720 will generally be secured to the distal end 150 of housing tube 120 by weld 760, or some other means of attachment such as gluing.
- backbone wire 720 has a rounded end 780 that is larger than the lumen of the unmodified section 180 and extends into tapered section 275 where it abuts the radioactive core 160.
- An important function of backbone wire 720 is to increase the strength of source wire 70 without reducing the flexibility of source wire 70.
- backbone wire 720 like the housing tube 120, is composed of a very flexible material with sufficient tensile strength to undergo the stress encountered when the source wire 70 is maneuvered to a treatment site. Therefore, backbone wire 720 should be constructed of a material with properties similar to that of housing tube 120. In fact, if the backbone wire 720 is welded to the distal end of tube 120 then the backbone wire 720 and tube 120 should be made of the same material, such as a titanium/nickel alloy as described above.
- backbone wire 720 Another important function of backbone wire 720 is to serve as a safety mechanism. Since rounded end 780 fits against the proximal end of unmodified section 180 and is too large to fit within the lumen of unmodified section 180 while the other end of backbone wire 720 is attached to the distal end 150, backbone wire 720 will prevent the radioactive core from separating from the rest of the source wire 70 even if the housing tube 120 were to break anywhere along the unmodified section 180. It is important that the radioactive core 160 remain attached to the distal end of the source wire so that it will be retracted from the patient when the source wire is withdrawn from the patient.
- backbone wire 720 may extend into the tapered section 275 such that the rounded end 780 will suspend radioactive core 160 within the tapered section 275.
- This embodiment of the backbone wire may be affixed to the inner surface 130 of housing tube 120 at a variety of attachment sites 830 to prevent the migration of radioactive material into the unmodified section 180.
- the backbone wire may be attached to the inner surface 130 by welding, fusing, soldering, gluing, etc.
- Attachment sites 830 may also provide an internal safety device that insures if housing tube 120 were to break at any point distal to an attachment site that the radioactive core 160 would not separate from the backbone wire and could be retracted from the patient.
- Backbone wire 820 has a proximal end that is configured like plug 590 with a tapered area 897 and a rounded area 895.
- the proximal end of backbone wire 820 thus provides all of the advantages discussed for plug
- FIGURE 9 illustrates a source wire 90 that is very much like source wire 70, except that radioactive core 160 is encapsulated in a thin-walled capsule 920 of a neutron permeable material.
- Capsule 920 differs from capsule 680 in that its distal end that abuts the rounded end 780 of backbone wire 720 has been extended to include a tapered area 940 and a rounded area 950.
- This configuration of capsule 920 increases the flexibility of source wire 90 at the junction of backbone wire 720 and the distal end of capsule 920 thereby increasing the flexibility of source wire 90 at tapered section 275.
- radioactive core 160 will be encapsulated in capsule 920 before the radioactive core is sent to a nuclear reactor for activation.
- elements of source wire 90 may be integrated into a source wire with elements of source wire 50 or 80. All 5 such permutations and variations are within the scope of the appended claims.
- An optional feature of all the source wires described herein would be to coat the exterior surface of the source wire with a non-oxidizing 0 agent, such as gold.
- a thin gold layer (from approximately 1 to 10 microns thick) would be electroplated over the outer surface of metal housing tube 120, or at least that portion of the surface overlying the radioactive core 160 and preferably over the proximal end of the source wire.
- the gold coating of the source wire would preferably be done prior to loading the radioactive core 160 into the modified segment 170 of housing tube 120.
- the fabrication of the source wires shown in FIGURES 0 1_ 9 above is described below.
- the first step in the manufacture of the described source wires is to obtain the metal tubing that will be used to make housing tube 120. Once the tubing is acquired, a calibrated micrometer for measuring the outside diameter and calibrated rods for measuring the inside diameter are used to validate that the tubing meets the manufacturer's specifications.
- the present invention can be made from any type of metal tube, however, the preferred embodiments are made from memory-resistant materials (i.e., materials that can accept up to a 1% strain with less than a 1% permanent alteration in its original configuration) .
- the preferred embodiment of the present invention uses Tinel Alloy BB tubing having an external diameter of 0.014" from Raychem Corporation.
- Housing tube 120 is constructed of a hollow tube with an inside diameter at least 0.001" smaller than the outside diameter of the radioactive core 160, or encapsulated core.
- a second step in the manufacture of the source wire is to modify the proximal end of the tubing to accept the radioactive core 160.
- a short segment of housing tube 120, said segment at least the length of radioactive core 160, will have material removed from the inner surface 130 of housing tube 120 to create a modified segment 170.
- Typically at least 0.002" of material will be removed from the inner surface 130 of housing tube 120 by grinding, reaming, EDM, drilling, laser boring, or similar methods.
- the internal diameter of modified segment 170 will be at least 0.004" wider than the internal diameter of the unmodified section 180 of tube
- the wall thickness of the modified section will be at least 0.002" thinner than the wall thickness of the unmodified section of tube 120.
- Tapered section 275 can be created using a tapered reamer, a tapered drill bit, a series of drill bits, a series of EDM probes, or a series of laser probes so that a portion of the inner surface 130 will be reconfigured to taper from the larger internal diameter
- Tapered section 275 will typically be at least five (5) millimeters long.
- the end result will be a cavity wide enough and long enough to house the entire length of the radioactive core plus at least one (1) millimeter.
- the distal end of the cavity may contain a tapered section 275 going from the larger inside diameter, housing the radioactive core, to the smaller original inside diameter of the tubing.
- the radioactive core 160 When the radioactive core 160 is inserted into the proximal end of the source wire it may extend into the tapered section 275. A gap should exist between the walls of the tapered section 275 and the outside diameter of the radioactive core 160. If the cavity is accidentally made too long, the modified segment 170 may be shorten by grinding, sanding, filing, or similar means until the correct overall dimensions are achieved. If a non-memory resistant material (a material where a 1% strain results in at least a 1% permanent alteration in its original configuration) is used, then different methods can be used to produce the required dimensions of the tubing and the cavity for holding the radioactive core 160. Non-memory resistant tubing can be reduced in
- a removable mandrel would be placed inside the tubing and the tubing would be drawn down or swaged forward through a diamond die to a point prior to the required inside taper, to achieve the proper outside diameter and inside the diameter of this length of tubing.
- a tapered removable mandrel with the proper diameter would now be placed in the remaining portion of the tubing and the tubing would be swaged forward or drawn down through the die creating the required dimensions of the taper and cavity within the proximal end of the tubing 120.
- a split die or a die that can break apart and be clamped back together allows precise positioning of the removable mandrels. If the cavity of the tubing is too long, the proximal end may be shorten by grinding, sanding, filing, or similar means until the correct overall dimensions are achieved. If necessary, several methods involving grinding, polishing, honing, and/or glazing can be applied to the inner walls of the modified segment 170 and tapered section 275 to seal any breaks in the integrity of housing tube 120 and to remove any micro-cracks or micro- voids that might be present due to the removal of the inner wall material:
- polishing, honing, or grinding can be accomplished by the use of a rotating rod (or tapered rod) encrusted or coated with a very fine abrasive;
- glazing can be accomplished by using a heated rotating rod (or tapered rod) with or without abrasive; or
- glazing may be accomplished using a laser fiber.
- backbone wire 720 is a solid wire of Tinel Alloy BB with a diameter of about 0.003".
- Rounded end 780 of backbone wire 720 is produced using the heat from a TIG welder. Once rounded end 780 has been formed, backbone wire 720 will be threaded from the proximal end of tube 120 towards the distal end of tube 120 until rounded end 780 reaches the proximal end of the unmodified section 180.
- backbone wire can be secured by cutting the wire where it extends from the distal end of tube 120 and welding the distal end of the backbone wire 720 to the distal end of tube 120. If the backbone wire and the tube are not constructed of the same material, the distal ends of the wire and the tube may be joined using a number of other methods known in the art.
- backbone wire 820 The alternative embodiment of a backbone wire illustrated in FIGURE 8 (backbone wire 820) is made by
- the Tinel Alloy BB wire ordered and grinding it down with an electric sander.
- the wire is held in a pin vise and rotated while grinding to taper the wire.
- the tapering can be done automatically or manually.
- the tapered end is examined under a microscope and with a micrometer to ensure that it is tapered sufficiently (i.e., with the right degree of reduction in the diameter of the wire and that it is evenly tapered) .
- the rounded area 895 is formed on the tapered end of backbone wire 820.
- the rounded area 895 is formed by heating the tapered end of backbone wire 820 with an arc welder after placing the tapered end of backbone wire 820 into a heat sink (preferably made of aluminum, copper, brass, or any other material that will absorb heat away from the protected object) at a predetermined distance above the heat sink.
- a heat sink preferably made of aluminum, copper, brass, or any other material that will absorb heat away from the protected object.
- the dimensions of the rounded area 895, or ball will be determined by the gap between the top of the wire and the bottom of the tungsten welding rod and by the length of the wire above the heat sink that is exposed to the heat of the TIG welder.
- the backbone wire is placed 0.025" (or about 0.1 mm) above a heat sink using a feeler gauge.
- a feeler gauge is also used to set a gap of about 0.030" between the top of the backbone wire and the bottom of the welding rod.
- the tapered end of backbone wire 820 is placed the proper distance from the heat sink and the welding rod, the tapered end of backbone wire 820 is exposed to a TIG welder.
- the metal above the heat sink will melt and form a rounded area 895. Typically, the rounded area will be
- backbone wire 720 Smaller in diameter than the inside diameter of the modified section 170
- a rounded end 780 too large to fit into the lumen of the unmodified section 180, but small enough to fit into the tapered section 275
- the non-rounded end should be advanced from the proximal end of tubing 120 until it exits out the distal end.
- the wire is then pulled from the distal end until the rounded end is flushed with proximal end 140 of tubing 120.
- a mark is placed on the distal end of the backbone wire at the point where it exits the tubing.
- the backbone wire is then pulled distally until the mark is at a distance away from the distal end of the tubing equal to at least the length of the radioactive core 160 plus one millimeter.
- a thin measuring wire is inserted from the proximal end until it touches the rounded end 780 of backbone wire 720.
- a mark or tape is placed on the measuring wire at the point where the wire is exiting the tubing.
- the measuring wire is removed and placed on a calibrated ruler to determine the proper distance. If the backbone wire is not properly seated, it will need to be pulled deeper into the tubing or advanced out towards the proximal end if it is seated too deep. If it can not be advanced any deeper due to the diameter of the rounded
- the diameter of the rounded end 780 can be reduced by lightly grinding or sanding it until it is seated at the proper depth inside the tubing.
- backbone wire 820 To insert the embodiment of backbone wire 820 into housing tube 120 a wire of about 32 mm in length is threaded into the lumen of the housing tube at what will become the proximal end 140 of the tube 120.
- the backoone wire 820 s tnen threaded through the distal ene of the lumen of the housing tube 120 until it reaches the 32 mm wire placed at tne proximal end of the tube 120.
- the backbone wire is marked where it exits the distal end of the tube 120.
- the backbone wire is then cut at the mark and is rethreaded into the lumen of the housing tube 120 so that the cut end of backbone wire 820 is flush with the distal end of housing tube 120.
- the distal end of the backbone wire is then welded to the distal end of tube 120 with a TIG welder. Repeated exposure to the TIG welder increases the diameter of the rounded end.
- This provides a rounded end 150 of the source wire that has a slightly larger diameter than tube 120 and provides an end that can be inserted into an afterloader, where the source wire can be held in place by the rounded end 150 and a set screw that is tightened into the wire just below the rounded end 150.
- the next step entails the placing of a plug, a stopper, or a seal in housing tube 120 where it can restrict the access of radioactive materials into the lumen of unmodified section 180.
- the length of backbone wire 720 on the distal end from the point where it exits the tubing to the end of the wire is measured.
- the backbone wire is than advanced out the proximal end and a slow drying glue or epoxy can be applied to the backbone wire a couple of centimeters distal to the rounded end 780.
- the backbone wire is then pulled from the distal end back into position until the length of wire exiting the distal end of the tubing matches exactly with the measured length above. At this point, the backbone wire is cut flush to the distal end 150 where it exits the tubing and is welded, soldered, epoxyed, glued, etc. permanently to the tubing. This end is then rounded.
- this backbone wire can be attached to the inner housing at several points by means of spot welding, or the use of gluing as described above. Since backbone wire 720 has a smaller diameter than the diameter of the lumen of unmodified section 180, a small gap 730 will exist between the outer surface of the backbone wire and the inner surface of the housing tube 130 to allow the wire to be attached to the housing at different locations. These attachment sites may also serve as a seal to prevent the migration of radioactive particles and as a safety wire if the outer housing material should break along unmodified section 180. If glue or epoxy is used, once it has dried, the cavity may be cleared of any residue glue or epoxy by reaming, drilling, honing, grinding, etc.
- backbone wire 720 does not need to be attached to the housing tube 120 at various sites to serve as a security device. Since the larger rounded end
- the backbone wire 720 would serve as a safety mechanism and keep the radioactive core from separating from the rest of the wire.
- a similar method of sealing the lumen of the unmodified section 180 described above can be used with backbone wire 820 having a proximal end with a taper 897 and a smaller rounded end 895.
- This smaller rounded end 895 with the tapered segment would be positioned inside the tapered section 275 of the housing material so that a gap would exist between the inner wall 130 and the tapered rounded segment of backbone wire 830.
- this gap should not be large enough to allow the radioactive core to advance distal to the rounded backbone end 895.
- a small plug or a small segment of the backbone wire
- the plug should be rounded as illustrated in
- Plug 190, 290 and 590 will have to be positioned from the proximal end.
- a temporary backbone wire would be placed from the distal end and used as a stopper to help position the plug.
- a section of the plug below the rounded end 195, 295, or 595 can be permanently fixed to the housing material by r.eans of spot welding, or by applying a slow-drying glue, epoxy, etc. to the plug prior to loading it into position. The temporary backbone wire is removed after the spot welding takes place or prior to the glue or epoxy permanently hardening into position.
- Another method of securing the plug to the inner wall 130 of housing tube 120 would be to temporarily use the backbone wire as described above. Once the plug was in place, it would be held from advancing forward by a wire in the proximal end. The backbone wire would be removed and a small piece of hardening agent that would have a low melting temperature, such as solder or glue (such as the glue used for hot glue guns) , would be loaded and advance from the distal end by means of the backbone wire until the hardening agent reached the plug. The tubing would be held with the proximal end down (still containing the wire positioning the plug in place) and the backbone wire would be removed.
- a low melting temperature such as solder or glue (such as the glue used for hot glue guns)
- Heat lower temperature than what would be needed to affect the properties of the plug and housing material
- Heat would be applied to the area where the hardening agent meets the plug, until the hardening agent meits and seals the plug to the inner housing wall. Once the sealing agent has dried, a quick test by trying to advance the plug in either ⁇ irection would assure that the plug is fixed at the proper location.
- An optional feature of the source wire embodiments is to attach the backbone wire to the inner surface of the housing tube 120 by welding, fusing, soldering, gluing, etc.
- Sites of attachment 830 are shown in FIGURE 8. These sites of attachment 830 provide an internal safety device that insures that if the housing tube 120 were to break that the radioactive core 160 would not separate from the backbone wire 830 and could be retracted from the patient.
- Attachment sites 830 may also act as seals to prevent the migration of radioactive materials into the distal regions of the unmodified section 180. Such attachment sites 830 may be made by a number of methods.
- One such method would be to thread the backbone wire 820 through the length of the housing tube.
- the distal end of the wire would be marked at the point where the proximal end of the wire is flush with the proximal end of the housing tube 120.
- the backbone wire would then be pushed forward and a small amount of slow drying epoxy placed around the circumference of the backbone wire 820 about two centimeters from the proximal end of the wire.
- the wire would be pulled back into the housing tube until the mark on the distal end extended from the distal end of the housing tube the appropriate distance, preferably about 32 mm.
- the backbone wire would then be cut flush with the distal end of the wire and welded to the housing tube to seal the distal end of the backbone wire 820. Any glue
- attachment sites 830 would be to follow the procedure described above, except tc allow the epoxy to dry before drawing the proximal end of the backbone wire back into the housing tube. The epoxy ring would then be ground or sanded to fit snugly within the housing tube 120. Attachment sites 830 would encircle backbone wire 830 closing off gap 730 and thereby preventing any "flakes" from the radioactive core 160 from migrating through gap 730 between the backbone wire 820 and the inner surface of housing tube
- Another method to create a plug or stopper would be to use a small piece of flexible metal, latex, elastic, rubber, etc. and position distal to or at the bottom of the tapered section 275. Once again, depending on the material used, glue, epoxy, solder, welding, etc. could be used to hold the material into position.
- the next step would typically be to load the radioactive core 160 into the proximal end of tubing 120.
- a preferred method is to set the proximal end of housing tube 120 about 0.025" above a heat sink 1010.
- the heat sink is also used as a clamping device to hold the wire in place.
- a gap of about 0.035" is set between the top of the housing tube 120 and the bottom of the welding rod.
- an iridium fiber which has been irradiated in a nuclear reactor to the desired radioactivity and held for 11 to 14 days to purge the iridium fiber of any short lived radioactive contaminants, is removed from its container.
- the iridium fiber may or may not be encapsulated as described above.
- the iridium fiber is preferably greater than 20 mm in length and is typically about 30 mm in length and about 0.005" in outside diameter.
- the radioactive iridium fiber is loaded into the housing tube 120 using a funnel.
- the iridium fiber is made flush with the bottom of the funnel.
- a small rod having a proper length and outside diameter, is used to countersink the Ir-192 about 2 mm from the top of the housing tube 120.
- the funnel is then removed.
- the assembly of the radioactive core 160 into the housing tube 120 is done using hand manipulators behind a leaded glass with lead shields so that the human assembler is not exposed to radiation.
- the forceps, funnel and heat sink used during the process that may have touched the radioactive core 160 must be decontaminated or disposed of properly.
- the exposed proximal end 140 of tube 120 is subjected to the heat of a TIG welder. This fuses the exposed end of the housing tube. Without the heat sink the heat would go directly to the iridium fiber and would oxidize, vaporize or fracture the iridium core 160 causing contamination of the outside surface of the source wire rendering it unusable. However, if the
- housing tube is placed a distance Y above the heat sink 1010 and the radioactive core 160 is placed a distance X below the top of the heat sink 1010 then the TIG welder will cause the tube 120 to seal the proximal end 140 of the source wire without affecting the radioactive core
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96939503A EP0873157A1 (en) | 1995-11-09 | 1996-11-12 | Improved flexible source wire for localized internal irradiation of tissue |
JP9518220A JP2000500040A (en) | 1995-11-09 | 1996-11-12 | Improved flexible radiation source wire for local internal irradiation of tissue |
CA002237168A CA2237168A1 (en) | 1995-11-09 | 1996-11-12 | Improved flexible source wire for localized internal irradiation of tissue |
AU76656/96A AU7665696A (en) | 1995-11-09 | 1996-11-12 | Improved flexible source wire for localized internal irradiation of tissue |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/556,250 | 1995-11-09 | ||
US08/556,250 US5833593A (en) | 1995-11-09 | 1995-11-09 | Flexible source wire for localized internal irradiation of tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997017104A1 true WO1997017104A1 (en) | 1997-05-15 |
Family
ID=24220539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/017260 WO1997017104A1 (en) | 1995-11-09 | 1996-11-12 | Improved flexible source wire for localized internal irradiation of tissue |
Country Status (6)
Country | Link |
---|---|
US (2) | US5833593A (en) |
EP (1) | EP0873157A1 (en) |
JP (1) | JP2000500040A (en) |
AU (1) | AU7665696A (en) |
CA (1) | CA2237168A1 (en) |
WO (1) | WO1997017104A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6723052B2 (en) | 2001-06-07 | 2004-04-20 | Stanley L. Mills | Echogenic medical device |
EP1667595A2 (en) * | 2003-09-12 | 2006-06-14 | Minnow Medical, LLC | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US7232408B1 (en) | 1999-06-18 | 2007-06-19 | Aea Technology Qsa Gmbh | Radiation source for endovascular radiation treatment |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US11504546B2 (en) | 2019-02-28 | 2022-11-22 | Cowles Ventures, Llc | Needle guidance device for brachytherapy and method of use |
US11524176B2 (en) | 2019-03-14 | 2022-12-13 | Cowles Ventures, Llc | Locator for placement of fiducial support device method |
Families Citing this family (144)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0813894B1 (en) | 1993-07-01 | 2001-12-05 | Schneider (Europe) GmbH | Medical appliances for the treatment of blood vessels by means of ionizing radiation |
US5857956A (en) | 1994-06-08 | 1999-01-12 | United States Surgical Corporation | Flexible source wire for localized internal irradiation of tissue |
ATE170708T1 (en) | 1994-06-10 | 1998-09-15 | Schneider Europ Gmbh | MEDICINAL DEVICE FOR THE TREATMENT OF A PART OF BODY VESSEL USING IONIZATION RADIATION |
EP0688580B1 (en) | 1994-06-24 | 2000-10-04 | Schneider (Europe) GmbH | Medical appliance for the treatment of a portion of body vessel by ionising radiation |
US5833593A (en) * | 1995-11-09 | 1998-11-10 | United States Surgical Corporation | Flexible source wire for localized internal irradiation of tissue |
US6099454A (en) | 1996-02-29 | 2000-08-08 | Scimed Life Systems, Inc. | Perfusion balloon and radioactive wire delivery system |
US5855546A (en) | 1996-02-29 | 1999-01-05 | Sci-Med Life Systems | Perfusion balloon and radioactive wire delivery system |
US6234951B1 (en) | 1996-02-29 | 2001-05-22 | Scimed Life Systems, Inc. | Intravascular radiation delivery system |
AU5806098A (en) | 1997-01-03 | 1998-07-31 | Robin G. Smith | Methods and devices for ex vivo irradiation of autologous coronary bypass conduit |
US6312374B1 (en) | 1997-03-06 | 2001-11-06 | Progenix, Llc | Radioactive wire placement catheter |
US6676590B1 (en) | 1997-03-06 | 2004-01-13 | Scimed Life Systems, Inc. | Catheter system having tubular radiation source |
US6059713A (en) | 1997-03-06 | 2000-05-09 | Scimed Life Systems, Inc. | Catheter system having tubular radiation source with movable guide wire |
US6110097A (en) | 1997-03-06 | 2000-08-29 | Scimed Life Systems, Inc. | Perfusion balloon catheter with radioactive source |
US6059812A (en) | 1997-03-21 | 2000-05-09 | Schneider (Usa) Inc. | Self-expanding medical device for centering radioactive treatment sources in body vessels |
US6019718A (en) | 1997-05-30 | 2000-02-01 | Scimed Life Systems, Inc. | Apparatus for intravascular radioactive treatment |
EP1019145A1 (en) * | 1997-09-23 | 2000-07-19 | United States Surgical Corporation | Source wire for radiation treatment |
DE59708672D1 (en) | 1997-09-26 | 2002-12-12 | Schneider Europ Gmbh Buelach | Balloon catheter inflated with carbon dioxide for radiotherapy |
US6254552B1 (en) * | 1997-10-03 | 2001-07-03 | E.I. Du Pont De Nemours And Company | Intra-coronary radiation devices containing Ce-144 or Ru-106 |
US6264596B1 (en) | 1997-11-03 | 2001-07-24 | Meadox Medicals, Inc. | In-situ radioactive medical device |
WO1999024117A1 (en) | 1997-11-07 | 1999-05-20 | Global Vascular Concepts, Inc. | Device for intravascular delivery of beta emitting isotopes |
US6120540A (en) * | 1998-01-21 | 2000-09-19 | Apple; Marc G. | Radio prosthesis |
CA2320138C (en) * | 1998-02-05 | 2006-06-06 | Morishige, Fumie | Therapeutic instrument for treating or relieving psoriasis, atopic dermatitis, articular rheumatism and/or cancer or preventing the progress of these diseases and method of utilization thereof |
US6053858A (en) * | 1998-06-04 | 2000-04-25 | Advanced Cardiovascular Systems, Inc. | Radiation source |
US6413203B1 (en) | 1998-09-16 | 2002-07-02 | Scimed Life Systems, Inc. | Method and apparatus for positioning radioactive fluids within a body lumen |
US6354989B1 (en) * | 1998-10-14 | 2002-03-12 | Terumo Kabushiki Kaisha | Radiation source delivery wire and catheter assembly for radiation therapy provided with the same |
US20040058109A1 (en) * | 1999-03-10 | 2004-03-25 | Pierce Peter D. | Use of foamed adhesives to make paper cores or tubes |
US6132677A (en) * | 1999-04-26 | 2000-10-17 | Lockheed Martin Energy Research Corporation | Method for making radioactive metal articles having small dimensions |
DE69930568T2 (en) | 1999-06-18 | 2006-11-09 | Aea Technology Qsa Gmbh | Radiation source for endovascular irradiation |
KR20020030088A (en) | 1999-07-29 | 2002-04-22 | 인터벤셔널 테러피스 엘엘씨 | Integral capsule source wire and method of making |
US6551232B1 (en) * | 1999-08-19 | 2003-04-22 | New England Medical Center | Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof |
US6319189B1 (en) | 1999-09-13 | 2001-11-20 | Isotron, Inc. | Methods for treating solid tumors using neutron therapy |
US6352500B1 (en) | 1999-09-13 | 2002-03-05 | Isotron, Inc. | Neutron brachytherapy device and method |
DE69915287T2 (en) | 1999-09-20 | 2004-07-22 | Aea Technology Qsa Gmbh | Wire-shaped radiation source for endovascular radiation |
US6352501B1 (en) | 1999-09-23 | 2002-03-05 | Scimed Life Systems, Inc. | Adjustable radiation source |
US6203485B1 (en) | 1999-10-07 | 2001-03-20 | Scimed Life Systems, Inc. | Low attenuation guide wire for intravascular radiation delivery |
US6398709B1 (en) | 1999-10-19 | 2002-06-04 | Scimed Life Systems, Inc. | Elongated member for intravascular delivery of radiation |
US6295476B1 (en) | 1999-11-01 | 2001-09-25 | Medtronic, Inc. | Medical lead conductor fracture visualization method and apparatus |
JP2003528657A (en) | 2000-01-07 | 2003-09-30 | インターヴェンショナル セラピーズ エルエルシー | Energy filter system |
US6416457B1 (en) | 2000-03-09 | 2002-07-09 | Scimed Life Systems, Inc. | System and method for intravascular ionizing tandem radiation therapy |
US6302865B1 (en) | 2000-03-13 | 2001-10-16 | Scimed Life Systems, Inc. | Intravascular guidewire with perfusion lumen |
US6817995B1 (en) | 2000-04-20 | 2004-11-16 | Isotron ,Inc. | Reinforced catheter connector and system |
US6497645B1 (en) | 2000-08-28 | 2002-12-24 | Isotron, Inc. | Remote afterloader |
WO2002038199A2 (en) | 2000-11-08 | 2002-05-16 | Theragenics Corporation | Radioactive source wire and delivery catheter for brachytherapy |
JP2004513712A (en) * | 2000-11-14 | 2004-05-13 | アップル、マーク、ジー. | An implantable device that emits directional energy |
EP1545705A4 (en) | 2000-11-16 | 2010-04-28 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
US20010044650A1 (en) * | 2001-01-12 | 2001-11-22 | Simso Eric J. | Stent for in-stent restenosis |
US6875165B2 (en) | 2001-02-22 | 2005-04-05 | Retinalabs, Inc. | Method of radiation delivery to the eye |
US6761680B2 (en) * | 2001-11-02 | 2004-07-13 | Richard A. Terwilliger | Delivery system and method for interstitial radiation therapy using seed strands constructed with preformed strand housing |
US6820318B2 (en) | 2001-11-02 | 2004-11-23 | Ideamatrix, Inc. | System for manufacturing interstitial radiation therapy seed strands |
US7074291B2 (en) | 2001-11-02 | 2006-07-11 | Worldwide Medical Technologies, L.L.C. | Delivery system and method for interstitial radiation therapy using strands constructed with extruded strand housings |
US7060020B2 (en) * | 2001-11-02 | 2006-06-13 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy |
US7094198B2 (en) * | 2001-11-02 | 2006-08-22 | Worldwide Medical Technologies, Llc | Delivery system and method for interstitial radiation therapy using seed elements with ends having one of projections and indentations |
US6786858B2 (en) * | 2001-11-02 | 2004-09-07 | Ideamatrix, Inc. | Delivery system and method for interstitial radiotherapy using hollow seeds |
US6773390B2 (en) * | 2002-03-20 | 2004-08-10 | Cordis Corporation | Radioactive source ribbon assembly |
US6997862B2 (en) | 2003-05-13 | 2006-02-14 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy using seed strands with custom end spacing |
US20050080314A1 (en) * | 2003-10-09 | 2005-04-14 | Terwilliger Richard A. | Shielded transport for multiple brachytheapy implants with integrated measuring and cutting board |
AU2005214040B2 (en) | 2004-02-12 | 2011-03-31 | Neo Vista, Inc. | Methods and apparatus for intraocular brachytherapy |
US7563222B2 (en) | 2004-02-12 | 2009-07-21 | Neovista, Inc. | Methods and apparatus for intraocular brachytherapy |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US20060068362A1 (en) * | 2004-09-27 | 2006-03-30 | Ormco Corporation | Endodontic instrument with depth markers |
US8187159B2 (en) | 2005-07-22 | 2012-05-29 | Biocompatibles, UK | Therapeutic member including a rail used in brachytherapy and other radiation therapy |
US7736293B2 (en) | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
US8043366B2 (en) | 2005-09-08 | 2011-10-25 | Boston Scientific Scimed, Inc. | Overlapping stent |
CA2629648A1 (en) | 2005-11-15 | 2007-05-24 | Neovista Inc. | Methods and apparatus for intraocular brachytherapy |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US7988611B2 (en) | 2006-05-09 | 2011-08-02 | Biocompatibles Uk Limited | After-loader for positioning implants for needle delivery in brachytherapy and other radiation therapy |
US20070265487A1 (en) * | 2006-05-09 | 2007-11-15 | Worldwide Medical Technologies Llc | Applicators for use in positioning implants for use in brachytherapy and other radiation therapy |
US7878964B1 (en) | 2006-09-07 | 2011-02-01 | Biocompatibles Uk Limited | Echogenic spacers and strands |
US7874976B1 (en) | 2006-09-07 | 2011-01-25 | Biocompatibles Uk Limited | Echogenic strands and spacers therein |
AU2007299659B2 (en) * | 2006-09-21 | 2011-09-29 | Mico Innovations, Llc | A specially configured and surface modified medical device with certain design features that utilize the intrinsic properties of tungsten, zirconium, tantalum and/or niobium |
WO2008041230A1 (en) * | 2006-10-02 | 2008-04-10 | Ben-Gurion University Of The Negev Research And Development Authority | Thulium-based capsule and devices for use in high dose rate brachytherapy |
EP2296756A1 (en) | 2008-06-04 | 2011-03-23 | Neovista, Inc. | Handheld radiation delivery system for advancing a radiation source wire |
WO2010101142A1 (en) * | 2009-03-04 | 2010-09-10 | 株式会社パイオラックスメディカルデバイス | Core for guide wire and method of producing same |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US20120004493A1 (en) * | 2010-07-02 | 2012-01-05 | Hedger Troy S | System for delivering treatment agents |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
EP2765942B1 (en) | 2011-10-10 | 2016-02-24 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
EP2775948B1 (en) | 2011-11-08 | 2018-04-04 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
EP2779929A1 (en) | 2011-11-15 | 2014-09-24 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
WO2013096913A2 (en) | 2011-12-23 | 2013-06-27 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
WO2013101452A1 (en) | 2011-12-28 | 2013-07-04 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
EP2895095A2 (en) | 2012-09-17 | 2015-07-22 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
JP6074051B2 (en) | 2012-10-10 | 2017-02-01 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Intravascular neuromodulation system and medical device |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
WO2014143571A1 (en) | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
JP2016524949A (en) | 2013-06-21 | 2016-08-22 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation having a rotatable shaft |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
WO2015002787A1 (en) | 2013-07-01 | 2015-01-08 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP3019106A1 (en) | 2013-07-11 | 2016-05-18 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
EP3049007B1 (en) | 2013-07-19 | 2019-06-12 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
WO2015013205A1 (en) | 2013-07-22 | 2015-01-29 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
JP6159888B2 (en) | 2013-08-22 | 2017-07-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Flexible circuit with improved adhesion to renal neuromodulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
CN105530885B (en) | 2013-09-13 | 2020-09-22 | 波士顿科学国际有限公司 | Ablation balloon with vapor deposited covering |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
WO2015057521A1 (en) | 2013-10-14 | 2015-04-23 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
EP3057520A1 (en) | 2013-10-15 | 2016-08-24 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
JP6259099B2 (en) | 2013-10-18 | 2018-01-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Balloon catheter comprising a conductive wire with flexibility, and related uses and manufacturing methods |
CN105658163B (en) | 2013-10-25 | 2020-08-18 | 波士顿科学国际有限公司 | Embedded thermocouple in denervation flexible circuit |
WO2015103617A1 (en) | 2014-01-06 | 2015-07-09 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
EP3102136B1 (en) | 2014-02-04 | 2018-06-27 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
KR101951567B1 (en) * | 2017-10-24 | 2019-02-22 | 국립암센터 | Apparatus for body-inserting having controllable direction and shape of radiation |
US11458330B2 (en) | 2019-05-29 | 2022-10-04 | Arnold M. Herskovic | Fluidized brachytherapy system and method |
US10967198B2 (en) | 2019-05-29 | 2021-04-06 | Arnold Herskovic | Brachytherapy stent configurations |
US11684759B2 (en) * | 2020-01-22 | 2023-06-27 | Abbott Cardiovascular Systems Inc. | Guidewire having varying diameters and method of making |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733655A (en) | 1985-09-20 | 1988-03-29 | S.A. Faco | Electric massage appliance |
US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
US5084002A (en) | 1988-08-04 | 1992-01-28 | Omnitron International, Inc. | Ultra-thin high dose iridium source for remote afterloader |
US5199939A (en) * | 1990-02-23 | 1993-04-06 | Dake Michael D | Radioactive catheter |
US5282781A (en) | 1990-10-25 | 1994-02-01 | Omnitron International Inc. | Source wire for localized radiation treatment of tumors |
US5395300A (en) * | 1991-06-07 | 1995-03-07 | Omnitron International, Inc. | High dosage radioactive source |
US5503614A (en) * | 1994-06-08 | 1996-04-02 | Liprie; Samuel F. | Flexible source wire for radiation treatment of diseases |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2865376A (en) * | 1956-03-27 | 1958-12-23 | American Cyanamid Co | Gold plating surgical needles |
US3351049A (en) * | 1965-04-12 | 1967-11-07 | Hazleton Nuclear Science Corp | Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture |
US4323055A (en) * | 1980-04-08 | 1982-04-06 | Minnesota Mining And Manufacturing Company | Radioactive iodine seed |
US5141487A (en) * | 1985-09-20 | 1992-08-25 | Liprie Sam F | Attachment of radioactive source and guidewire in a branchy therapy source wire |
US4763642A (en) * | 1986-04-07 | 1988-08-16 | Horowitz Bruce S | Intracavitational brachytherapy |
US4819618A (en) * | 1986-08-18 | 1989-04-11 | Liprie Sam F | Iridium/platinum implant, method of encapsulation, and method of implantation |
US4762130A (en) * | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
US4834724A (en) * | 1987-04-06 | 1989-05-30 | Geiss Alan C | Device for aspirating fluids from a body cavity or hollow organ |
JPS6446056U (en) * | 1987-09-17 | 1989-03-22 | ||
US4891165A (en) * | 1988-07-28 | 1990-01-02 | Best Industries, Inc. | Device and method for encapsulating radioactive materials |
US4861520A (en) * | 1988-10-28 | 1989-08-29 | Eric van't Hooft | Capsule for radioactive source |
US5342283A (en) * | 1990-08-13 | 1994-08-30 | Good Roger R | Endocurietherapy |
US5213561A (en) * | 1990-09-06 | 1993-05-25 | Weinstein Joseph S | Method and devices for preventing restenosis after angioplasty |
US5354257A (en) * | 1991-01-29 | 1994-10-11 | Med Institute, Inc. | Minimally invasive medical device for providing a radiation treatment |
DE9102312U1 (en) * | 1991-02-27 | 1992-06-25 | Weikl, Andreas, Dr.Med. | |
CA2074304C (en) * | 1991-08-02 | 1996-11-26 | Cyril J. Schweich, Jr. | Drug delivery catheter |
AU2597292A (en) * | 1991-09-05 | 1993-04-05 | Cedars-Sinai Medical Center | Method and apparatus for restenosis treatment |
US5302168A (en) * | 1991-09-05 | 1994-04-12 | Hess Robert L | Method and apparatus for restenosis treatment |
US5226888A (en) * | 1991-10-25 | 1993-07-13 | Michelle Arney | Coiled, perfusion balloon catheter |
US5295959A (en) * | 1992-03-13 | 1994-03-22 | Medtronic, Inc. | Autoperfusion dilatation catheter having a bonded channel |
US5342158A (en) * | 1992-09-30 | 1994-08-30 | Gamma-Metrics | Handling and deploying radioactive sources |
US5308356A (en) * | 1993-02-25 | 1994-05-03 | Blackshear Jr Perry L | Passive perfusion angioplasty catheter |
US5383856A (en) * | 1993-03-19 | 1995-01-24 | Bersin; Robert M. | Helical spiral balloon catheter |
US5643171A (en) * | 1993-05-04 | 1997-07-01 | Neocardia, Llc | Method and apparatus for uniform radiation treatment of vascular lumens |
JPH09501326A (en) | 1993-05-04 | 1997-02-10 | オムニトロン インターナショナル インコーポレイテッド | Radiation source wire, device using the same, and treatment method |
US5540659A (en) * | 1993-07-15 | 1996-07-30 | Teirstein; Paul S. | Irradiation catheter and method of use |
US5484411A (en) * | 1994-01-14 | 1996-01-16 | Cordis Corporation | Spiral shaped perfusion balloon and method of use and manufacture |
US5503613A (en) * | 1994-01-21 | 1996-04-02 | The Trustees Of Columbia University In The City Of New York | Apparatus and method to reduce restenosis after arterial intervention |
US5618266A (en) * | 1994-03-31 | 1997-04-08 | Liprie; Samuel F. | Catheter for maneuvering radioactive source wire to site of treatment |
US5857956A (en) * | 1994-06-08 | 1999-01-12 | United States Surgical Corporation | Flexible source wire for localized internal irradiation of tissue |
US5833593A (en) * | 1995-11-09 | 1998-11-10 | United States Surgical Corporation | Flexible source wire for localized internal irradiation of tissue |
US5713828A (en) * | 1995-11-27 | 1998-02-03 | International Brachytherapy S.A | Hollow-tube brachytherapy device |
NL1003543C2 (en) * | 1996-07-08 | 1998-01-12 | Optische Ind Oede Oude Delftoe | Brachytherapy capsule and brachytherapy capsule assembly and guide. |
US5782741A (en) * | 1996-11-12 | 1998-07-21 | Guidant Coropration | Two-stage treatment wire |
US6019718A (en) * | 1997-05-30 | 2000-02-01 | Scimed Life Systems, Inc. | Apparatus for intravascular radioactive treatment |
US6273850B1 (en) * | 1997-10-29 | 2001-08-14 | Medtronic Ave, Inc. | Device for positioning a radiation source at a stenosis treatment site |
US5851171A (en) * | 1997-11-04 | 1998-12-22 | Advanced Cardiovascular Systems, Inc. | Catheter assembly for centering a radiation source within a body lumen |
US5957829A (en) * | 1997-12-17 | 1999-09-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for radiotherapy using a radioactive source wire having a magnetic insert |
US6080099A (en) * | 1998-08-12 | 2000-06-27 | Syntheon, Llc | Radioactive therapeutic seeds |
US6066083A (en) * | 1998-11-27 | 2000-05-23 | Syntheon Llc | Implantable brachytherapy device having at least partial deactivation capability |
-
1995
- 1995-11-09 US US08/556,250 patent/US5833593A/en not_active Expired - Fee Related
-
1996
- 1996-11-12 JP JP9518220A patent/JP2000500040A/en active Pending
- 1996-11-12 AU AU76656/96A patent/AU7665696A/en not_active Abandoned
- 1996-11-12 CA CA002237168A patent/CA2237168A1/en not_active Abandoned
- 1996-11-12 EP EP96939503A patent/EP0873157A1/en not_active Withdrawn
- 1996-11-12 WO PCT/US1996/017260 patent/WO1997017104A1/en not_active Application Discontinuation
-
1998
- 1998-10-12 US US09/169,891 patent/US6442822B1/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
US4733655A (en) | 1985-09-20 | 1988-03-29 | S.A. Faco | Electric massage appliance |
US5084002A (en) | 1988-08-04 | 1992-01-28 | Omnitron International, Inc. | Ultra-thin high dose iridium source for remote afterloader |
US5199939A (en) * | 1990-02-23 | 1993-04-06 | Dake Michael D | Radioactive catheter |
US5199939B1 (en) * | 1990-02-23 | 1998-08-18 | Michael D Dake | Radioactive catheter |
US5282781A (en) | 1990-10-25 | 1994-02-01 | Omnitron International Inc. | Source wire for localized radiation treatment of tumors |
US5395300A (en) * | 1991-06-07 | 1995-03-07 | Omnitron International, Inc. | High dosage radioactive source |
US5503614A (en) * | 1994-06-08 | 1996-04-02 | Liprie; Samuel F. | Flexible source wire for radiation treatment of diseases |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7232408B1 (en) | 1999-06-18 | 2007-06-19 | Aea Technology Qsa Gmbh | Radiation source for endovascular radiation treatment |
US6723052B2 (en) | 2001-06-07 | 2004-04-20 | Stanley L. Mills | Echogenic medical device |
US8560052B2 (en) | 2001-06-07 | 2013-10-15 | Core Oncology, Inc. | Echogenic medical device |
EP1667595A2 (en) * | 2003-09-12 | 2006-06-14 | Minnow Medical, LLC | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
EP1667595A4 (en) * | 2003-09-12 | 2009-06-03 | Minnow Medical Llc | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US10188457B2 (en) | 2003-09-12 | 2019-01-29 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9510901B2 (en) | 2003-09-12 | 2016-12-06 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8939970B2 (en) | 2004-09-10 | 2015-01-27 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US10213252B2 (en) | 2006-10-18 | 2019-02-26 | Vessix, Inc. | Inducing desirable temperature effects on body tissue |
US10413356B2 (en) | 2006-10-18 | 2019-09-17 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US9327100B2 (en) | 2008-11-14 | 2016-05-03 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US11504546B2 (en) | 2019-02-28 | 2022-11-22 | Cowles Ventures, Llc | Needle guidance device for brachytherapy and method of use |
US11524176B2 (en) | 2019-03-14 | 2022-12-13 | Cowles Ventures, Llc | Locator for placement of fiducial support device method |
Also Published As
Publication number | Publication date |
---|---|
AU7665696A (en) | 1997-05-29 |
US5833593A (en) | 1998-11-10 |
JP2000500040A (en) | 2000-01-11 |
EP0873157A1 (en) | 1998-10-28 |
CA2237168A1 (en) | 1997-05-15 |
US6442822B1 (en) | 2002-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5833593A (en) | Flexible source wire for localized internal irradiation of tissue | |
US6505392B1 (en) | Process for manufacturing a radioactive source wire for irradiating diseased tissue | |
US6506145B1 (en) | Radioactive source wire, apparatus and treatment methods | |
US6013019A (en) | Temporary radioisotope stent | |
US6176821B1 (en) | Radiation delivery balloon catheter | |
US6338709B1 (en) | Intravascular radiation therapy device and method of use | |
US6641607B1 (en) | Double tube stent | |
EP0810004A2 (en) | Radiation-emitting flow-through temporary stent | |
JPH09173481A (en) | Filament for radiotherapy for living body | |
JP2003504126A (en) | Radioactive source train | |
US7232408B1 (en) | Radiation source for endovascular radiation treatment | |
EP1133331A1 (en) | Adjustable radiation source | |
US6464626B1 (en) | Catheter assembly incorporating radiation shielding and related method of use | |
AU752979B2 (en) | Improved flexible source wire for localized internal irradiation of tissue | |
US6485405B1 (en) | Method of making a sourcewire with integral capsule | |
WO1998034681A1 (en) | Apparatus and method for intravascular radiotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2237168 Country of ref document: CA Ref country code: CA Ref document number: 2237168 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 518220 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996939503 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1996939503 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996939503 Country of ref document: EP |